Find Us on Facebook Follow Us on Twitter Find Us on Youtube Bookmark & Share Subscribe to Feed

Cancer News: Roche stock up $12 billion on cancer, hemophilia trials; rivals hit


ZURICH (Reuters) – Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines.


Reuters: Health News

Cancer News: Risk of breast cancer recurrence lasts for decades


(Reuters Health) – Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests.


Reuters: Health News

Cancer News: Monsanto, U.S. farm groups sue California over glyphosate warnings


CHICAGO (Reuters) – Monsanto Co and U.S. farm groups sued California on Wednesday to stop the state from requiring cancer warnings on products containing the widely used weed killer glyphosate, which the company sells to farmers to apply to its genetically engineered crops.


Reuters: Health News

Cancer News: Loxo signs lucrative cancer drug deal with Bayer, but shares fall


(Reuters) – Loxo Oncology on Tuesday signed a collaboration agreement for its promising cancer drugs with Germany’s Bayer AG that could be worth up to $ 1.55 billion to the tiny U.S. company, but its shares fell 11 percent as the deal appeared to end near-term likelihood of a takeover.


Reuters: Health News

Cancer News: Large U.S. farm study finds no cancer link to Monsanto weedkiller


LONDON, (Reuters) – A large long-term study on the use of the big-selling weedkiller glyphosate by agricultural workers in the United States has found no firm link between exposure to the pesticide and cancer, scientists said on Thursday.


Reuters: Health News